Cotización Defence Therapeutics - DTC

Herramientas de nivel profesional para inversores individuales.

Premium

Último Precio

0.60

Postura de Compra

0.58

Postura de Venta

0.68

Volume Operado de la Acción

37,025

0.60 Rango del Día 0.62

0.48 Rango de 52 semanas 2.32

Precio Anterior

0.65

Precio de Apertura

0.62

Hora

0.6

Última hora de negociación

Volumen promedio (3 m)

25,643

Volumen financiero

Precio Promedio Ponderado

DEFENCE RETAINS CATO SMS TO ADVISE ON ITS PHASE I CLINICAL TRIAL ON ACCUTOXTM FOR BREAST CANCER

DEFENCE RETAINS CATO SMS TO ADVISE ON ITS PHASE I CLINICAL TRIAL ON ACCUTOXTM FOR BREAST CANCER Vancouver, BC, Canada, February 16th, 2022 -- InvestorsHub NewsWire Defence Therapeutics Inc...

Defence's AccumTM-HPV vaccine formulation (AccuVAC-PT009) activates a 36-fold higher humoral response compared to Gardasil-9

Defence's AccumTM-HPV vaccine formulation (AccuVAC-PT009) activates a 36-fold higher humoral response compared to Gardasil-9 Vancouver, BC, Canada, January 26th...

DEFENCE THERAPEUTICS VACCINES AND PROGRAM DEVELOPMENT

Vancouver, BC, Canada -- November 30th 2021 -- InvestorsHub NewsWire -- Defence Therapeutics Inc. (CSE: DTC; FSE: DTC; USOTC: DTCFF) ("Defence" or the...

DEFENCE THERAPEUTICS CANCER VACCINE ACCUVAC-D001 MANUFACTURING TARGETS MELANOMA AND BREAST CANCER

DEFENCE THERAPEUTICS CANCER VACCINE ACCUVAC-D001 MANUFACTURING TARGETS MELANOMA AND BREAST CANCER Vancouver, BC, Canada -- November 23, 2021 -- InvestorsHub NewsWire...

DEFENCE THERAPEUTICS APPOINTS DR. RIAM SHAMMAA TO ITS BOARD OF DIRECTORS

DEFENCE THERAPEUTICS APPOINTS DR. RIAM SHAMMAA TO ITS BOARD OF DIRECTORS Vancouver, BC, Canada, November 9th, 2021 -- InvestorsHub NewsWire -- Defence Therapeutics Inc. CSE:DTC, USOTC:DTCFF...

VACCINE RESULTS: DEFENCE THERAPEUTICS REPORTS SUCCESSFUL COMPLETION OF ITS COVID-19 VACCINE ACCUVAC-PT001 TOXICOLOGY STUDIES IN RABBITS

VACCINE RESULTS: DEFENCE THERAPEUTICS REPORTS SUCCESSFUL COMPLETION OF ITS COVID-19 VACCINE ACCUVAC-PT001 TOXICOLOGY STUDIES IN RABBITS Vancouver, BC, Canada, November...

DEFENCE THERAPEUTICS ACCUMTM VARIANTS IN VITRO STUDY INCREASES THE POTENCY OF T-DERUXTECAN ADC BY 5-FOLD ON BREAST CANCER

DEFENCE THERAPEUTICS ACCUMTM VARIANTS IN VITRO STUDY INCREASES THE POTENCY OF T-DERUXTECAN ADC BY 5-FOLD ON BREAST CANCER Vancouver, BC, Canada, October 13th...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	-0.06	-9.09090909091	0.66	0.7	0.6	20200	0.65381188	CS
4	0.08	15.3846153846	0.52	0.76	0.49	34301	0.59874484	CS
12	-0.01	-1.6393442623	0.61	0.76	0.49	25643	0.57953825	CS
26	-0.27	-31.0344827586	0.87	0.96	0.48	27039	0.62637978	CS
52	-1.41	-70.1492537313	2.01	2.32	0.48	30214	1.0080792	CS
156	-4.5	-88.2352941176	5.1	5.25	0.48	19879	2.02769556	CS
260	-1.15	-65.7142857143	1.75	8.15	0.48	18743	2.50052613	CS

DTC - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Defence Therapeutics?

El precio actual de las acciones de Defence Therapeutics es $ 0.60

¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Defence Therapeutics?

Defence Therapeutics ha negociado en un rango de $ 0.48 a $ 2.32 durante el último año

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
PNGAPangea Natural Foods Inc	$ 0.04 (100.00%)	50k
AFXArctic Fox Lithium Corp	$ 0.01 (100.00%)	3k
HMHM Exploration Corp	$ 0.09 (80.00%)	4k
FREEFree Battery Metal Limited	$ 0.025 (66.67%)	1.28M
BFGGiant Mining Corp	$ 0.445 (50.85%)	16.6k
AUMCAuric Minerals Corp	$ 1.51 (-61.77%)	3.96M
RVVRevive Therapeutics Ltd	$ 0.005 (-50.00%)	1,000
PGOLPatriot Gold Corp	$ 0.015 (-50.00%)	8k
BLRBlackhawk Growth Corp	$ 0.005 (-50.00%)	3.17k
BEEBee Vectoring Technologies International Inc	$ 0.005 (-50.00%)	2.3k
AUMCAuric Minerals Corp	$ 1.51 (-61.77%)	3.96M
FNQFineqia International Inc	$ 0.005 (0.00%)	2.83M
QIMCQuebec Innovative Materials Corp	$ 0.095 (-13.64%)	2.72M
LEXTLexston Mining Corporation	$ 0.0175 (-30.00%)	1.88M
RAINRain City Resources Inc	$ 0.065 (0.00%)	1.52M